Shanghai, China

Xirong Cao

This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Joyu Pharmatech Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xirong Cao. Retrieved from https://idiyas.com/inventor/xirong-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xirong Cao: Innovator in Pharmaceutical Compounds

Introduction

Xirong Cao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Cao holds a patent for a compound designed to inhibit indoleamine 2,3-dioxygenase (IDO). This patent, titled "Compound for inhibiting IDO, a manufacturing method and a use thereof," represents a breakthrough in the treatment of various diseases. The compound is characterized by a specific general formula, which outlines its chemical structure and potential uses.

Career Highlights

Cao is currently employed at Shanghai Joyu Pharmatech Ltd., where he continues to engage in innovative research and development. His work focuses on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Throughout his career, Xirong Cao has collaborated with esteemed colleagues, including Yan Zhong and Yonglin Wang. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Xirong Cao's contributions to the pharmaceutical industry, particularly through his patent for an IDO-inhibiting compound, highlight his role as an influential inventor. His ongoing work at Shanghai Joyu Pharmatech Ltd. continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…